|
|
||||||||
Research Paper |
Department of Veterinary Microbiology, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Hokkaido 080-8555, Japan1
Author for correspondence: Masahisa Watarai. Tel: +81 155 49 5387. Fax: +81 155 49 5402. e-mail: watarai{at}obihiro.ac.jp
Brucella abortus is a facultative intracellular bacterium capable of surviving inside macrophages. The VirB complex, which is highly similar to conjugative DNA transfer apparatuses, is required for intracellular replication. A conserved NTP-binding domain in VirB4 suggests that one or both proteins couple energy by NTP hydrolysis to transport of putative effector molecule(s). Here it is shown that a mutant strain of B. abortus that contains an in-frame deletion in virB4 is unable to replicate in macrophages and survives in mice. Intracellular replication and virulence in mice are fully restored by expressing virB4 in trans, indicating that VirB4 is essential for intracellular replication and virulence in mice. An alteration within the NTP-binding region of VirB4 by site-directed mutagenesis abolished complementation of a virB4 mutant, demonstrating that an intact NTP-binding domain is critical for VirB4 function. Intracellular replication was inhibited in wild-type B. abortus after introducing a plasmid expressing a mutant VirB4 altered in the NTP-binding region. The dominant negative phenotype suggests that VirB4 either functions as a multimer or interacts with some other component(s) necessary for intracellular replication. Wild-type B. abortus-containing phagosomes lack the glycoprotein LAMP-1, which is an indicator of the normal endocytic pathway. Mutant strains were found in phagosomes that co-localized with LAMP-1, indicating that VirB4 containing the intact NTP-binding region is essential for evasion of fusion with lysosomes.
Keywords: type IV secretion, macrophage
This article has been cited by other articles:
![]() |
A. B. den Hartigh, H. G. Rolan, M. F. de Jong, and R. M. Tsolis VirB3 to VirB6 and VirB8 to VirB11, but Not VirB7, Are Essential for Mediating Persistence of Brucella in the Reticuloendothelial System J. Bacteriol., July 1, 2008; 190(13): 4427 - 4436. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Rolan, A. B. den Hartigh, M. Kahl-McDonagh, T. Ficht, L. G. Adams, and R. M. Tsolis VirB12 Is a Serological Marker of Brucella Infection in Experimental and Natural Hosts Clin. Vaccine Immunol., February 1, 2008; 15(2): 208 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Sun, H. G. Rolan, A. B. den Hartigh, D. Sondervan, and R. M. Tsolis Brucella abortus VirB12 Is Expressed during Infection but Is Not an Essential Component of the Type IV Secretion System Infect. Immun., September 1, 2005; 73(9): 6048 - 6054. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Yuan, A. Carle, C. Gao, D. Sivanesan, K. A. Aly, C. Hoppner, L. Krall, N. Domke, and C. Baron Identification of the VirB4-VirB8-VirB5-VirB2 Pilus Assembly Sequence of Type IV Secretion Systems J. Biol. Chem., July 15, 2005; 280(28): 26349 - 26359. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-A. Boigegrain, I. Salhi, M.-T. Alvarez-Martinez, J. Machold, Y. Fedon, M. Arpagaus, C. Weise, M. Rittig, and B. Rouot Release of Periplasmic Proteins of Brucella suis upon Acidic Shock Involves the Outer Membrane Protein Omp25 Infect. Immun., October 1, 2004; 72(10): 5693 - 5703. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pei and T. A. Ficht Brucella abortus Rough Mutants Are Cytopathic for Macrophages in Culture Infect. Immun., January 1, 2004; 72(1): 440 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Watarai, S. Kim, J. Erdenebaatar, S.-i. Makino, M. Horiuchi, T. Shirahata, S. Sakaguchi, and S. Katamine Cellular Prion Protein Promotes Brucella Infection into Macrophages J. Exp. Med., July 7, 2003; 198(1): 5 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Erdenebaatar, B. Bayarsaikhan, M. Watarai, S.-i. Makino, and T. Shirahata Enzyme-Linked Immunosorbent Assay To Differentiate the Antibody Responses of Animals Infected with Brucella Species from Those of Animals Infected with Yersinia enterocolitica O9 Clin. Vaccine Immunol., July 1, 2003; 10(4): 710 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rouot, M.-T. Alvarez-Martinez, C. Marius, P. Menanteau, L. Guilloteau, R.-A. Boigegrain, R. Zumbihl, D. O'Callaghan, N. Domke, and C. Baron Production of the Type IV Secretion System Differs among Brucella Species as Revealed with VirB5- and VirB8-Specific Antisera Infect. Immun., March 1, 2003; 71(3): 1075 - 1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Watarai, S.-i. Makino, M. Michikawa, K. Yanagisawa, S. Murakami, and T. Shirahata Macrophage Plasma Membrane Cholesterol Contributes to Brucella abortus Infection of Mice Infect. Immun., September 1, 2002; 70(9): 4818 - 4825. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |